Holen Sie sich die Stockscreener-App
1.67
0.60%
-0.01
Handel nachbörslich:
1.67
Schlusskurs vom Vortag:
$1.68
Offen:
$1.675
24-Stunden-Volumen:
291.47K
Relative Volume:
0.35
Marktkapitalisierung:
$102.52M
Einnahmen:
$5.03M
Nettoeinkommen (Verlust:
$-185.41M
KGV:
-0.5405
EPS:
-3.09
Netto-Cashflow:
$-139.79M
1W Leistung:
-7.22%
1M Leistung:
+9.87%
6M Leistung:
-1.18%
1J Leistung:
-88.50%
1-Tages-Spanne:
$1.64
$1.73
1-Wochen-Bereich:
$1.61
$1.83
52-Wochen-Spanne:
$1.1001
$16.10
Pliant Therapeutics Inc Stock (PLRX) Company Profile
Firmenname
Pliant Therapeutics Inc
Sektor
Branche
Telefon
650-481-6770
Adresse
331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA
Vergleichen Sie PLRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PLRX
Pliant Therapeutics Inc
|
1.67 | 103.13M | 5.03M | -185.41M | -139.79M | -3.09 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Pliant Therapeutics Inc Stock (PLRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-03-04 | Fortgesetzt | Cantor Fitzgerald | Neutral |
| 2025-03-04 | Herabstufung | Needham | Buy → Hold |
| 2025-03-03 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2025-03-03 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-10 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2025-02-10 | Herabstufung | Citigroup | Buy → Neutral |
| 2025-02-10 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2025-02-10 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-02-10 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2025-02-10 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2025-02-10 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2024-09-09 | Fortgesetzt | Leerink Partners | Outperform |
| 2023-12-08 | Eingeleitet | Wells Fargo | Overweight |
| 2023-05-18 | Eingeleitet | Canaccord Genuity | Buy |
| 2023-04-13 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-12-14 | Eingeleitet | Stifel | Buy |
| 2022-12-07 | Eingeleitet | JP Morgan | Overweight |
| 2022-09-01 | Eingeleitet | Citigroup | Buy |
| 2022-07-20 | Eingeleitet | SVB Leerink | Outperform |
| 2022-05-25 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2021-12-10 | Eingeleitet | Oppenheimer | Outperform |
| 2021-11-24 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2021-11-03 | Eingeleitet | H.C. Wainwright | Buy |
| 2021-04-20 | Eingeleitet | BTIG Research | Buy |
| 2021-04-05 | Eingeleitet | Citigroup | Buy |
| 2020-06-29 | Eingeleitet | Citigroup | Buy |
| 2020-06-29 | Eingeleitet | Cowen | Outperform |
| 2020-06-29 | Eingeleitet | Needham | Buy |
| 2020-06-29 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten
Why Pliant Therapeutics Inc. stock is favored by top institutionsMarket Performance Summary & Weekly High Potential Alerts - newser.com
Why Pliant Therapeutics Inc. (9PT) stock could be top winner2025 Technical Patterns & Low Drawdown Investment Ideas - newser.com
Why Pliant Therapeutics Inc. stock is in analyst buy zoneMarket Volume Summary & Safe Swing Trade Setup Alerts - newser.com
How rising interest rates impact Pliant Therapeutics Inc. stock2025 Biggest Moves & AI Powered Market Entry Strategies - newser.com
Pliant Therapeutics Inc expected to post a loss of 52 cents a shareEarnings Preview - TradingView
Technical signs of recovery in Pliant Therapeutics Inc.Trade Signal Summary & Daily Profit Focused Stock Screening - newser.com
Is Pliant Therapeutics Inc. stock near bottom after declineJuly 2025 Outlook & Daily Momentum Trading Reports - newser.com
What indicators show strength in Pliant Therapeutics Inc.July 2025 Retail & Daily Oversold Bounce Ideas - newser.com
Can Pliant Therapeutics Inc. (9PT) stock double in coming yearsPortfolio Growth Summary & Real-Time Market Trend Scan - newser.com
Does Pliant Therapeutics Inc. show high probability of reboundJuly 2025 Macro Moves & Accurate Intraday Trade Tips - newser.com
Will Pliant Therapeutics Inc. (9PT) stock outperform global peersJuly 2025 Sector Moves & Weekly Chart Analysis and Trade Guides - newser.com
Heatmap analysis for Pliant Therapeutics Inc. and competitorsMarket Movement Recap & Daily Chart Pattern Signal Reports - newser.com
Chart overlay techniques for tracking Pliant Therapeutics Inc.July 2025 Update & Fast Entry High Yield Tips - newser.com
Is Pliant Therapeutics Inc. stock cheap at current valuationShare Buyback & Precise Trade Entry Recommendations - newser.com
Analyzing recovery setups for Pliant Therapeutics Inc. investorsOptions Play & Weekly Chart Analysis and Guides - newser.com
Will Pliant Therapeutics Inc. stock deliver shareholder valueTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com
Price momentum metrics for Pliant Therapeutics Inc. explained2025 Institutional Moves & Accurate Entry/Exit Alerts - newser.com
Pliant Therapeutics (PLRX) Expected to Announce Earnings on Thursday - MarketBeat
Can Pliant Therapeutics Inc. stock maintain operating marginsJuly 2025 Gainers & Expert Approved Momentum Trade Ideas - newser.com
Is Pliant Therapeutics Inc. (9PT) stock worth buying before Fed actionWeekly Loss Report & Fast Momentum Stock Entry Tips - fcp.pa.gov.br
Finanzdaten der Pliant Therapeutics Inc-Aktie (PLRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):